EXCLUSIVE LICENSE AGREEMENT by and between HANMI PHARMACEUTICAL CO. LTD. and APTOSE BIOSCIENCES INC.Exclusive License Agreement • November 4th, 2021 • Aptose Biosciences Inc. • Biological products, (no disgnostic substances) • New York
This Agreement is effective as of November 4, 2021, (the “Effective Date”) and is entered into by and between HANMI PHARMACEUTICAL CO. LTD., a corporation organized and existing under the laws of the Republic of Korea (“Hanmi”) and APTOSE BIOSCIENCES INC., a corporation organized and existing under the laws of Ontario, Canada (“Aptose”).
